Malignant tumors
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: Patients with suspected or confirmed malignant tumors undergo PET/CT and/or PET/MRI for the purposes of diagnosis and differential diagnosis, searching for primary lesions, clinical staging, assessment of prognosis, and evaluation of therapeutic efficacy.
Exclusion criteria
Exclusion criteria: (1) Pregnant and lactating women. (2) Patients with poor autonomy (e.g., inability to lie down), severe claustrophobia, critically ill patients requiring life support, etc., who are unable to cooperate with the examination. (3) Patients with other conditions that make them unsuitable for the examination.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| PET/CT imaging; | — |
Secondary
| Measure | Time frame |
|---|---|
| Detection rate;SUVmax (maximum standard uptake volume);SUVmean mean standard uptake volume;TLG (total lesion glycolysis) /TLF (total lesion FAP expression) ;MTV (metabolic tumor volume)/ FTV(FAP expression tumor volume) ;TBR (tumor-to-background ratio) ; | — |
Countries
China
Contacts
The First Affiliated Hospital of Dalian Medical University